Chondrosarcoma: Chondrosarcoma is the second most frequent primary malignant tumor of bone, representing approximately 25% of all primary osseous neoplasms. Chondrosarcomas are a group of tumors with highly diverse features and behavior patterns, ranging from slow-growing non-metastasizing lesions to highly aggressive metastasizing sarcomas. More detailed information about the symptoms, causes, and treatments of Chondrosarcoma is available below.
Read more about symptoms of Chondrosarcoma
Read more about treatments for Chondrosarcoma
Home medical testing related to Chondrosarcoma:
Test for Chondrosarcoma in your own home
Click for TestsRead more about tests for Chondrosarcoma
Read more about complications of Chondrosarcoma.
Read more about causes of Chondrosarcoma
More information about causes of Chondrosarcoma:
Research the causes of these diseases that are similar to, or related to, Chondrosarcoma:
Commonly undiagnosed diseases in related medical categories:
Spitz nevi misdiagnosed as dangerous melanoma skin cancer: One possible misdiagnosis to consider in lieu of melanoma is spitz nevi. See melanoma and spitz nevi....read more »
Read more about Misdiagnosis and Chondrosarcoma
Research related physicians and medical specialists:
Other doctor, physician and specialist research services:
Research quality ratings and patient safety measures for medical facilities in specialties related to Chondrosarcoma:
Hospital & Clinic quality ratings »
Choosing the Best Hospital: More general information, not necessarily in relation to Chondrosarcoma, on hospital performance and surgical care quality:
Rare types of diseases and disorders in related medical categories:
Read more about the latest treatments for Chondrosarcoma
Prognosis for Chondrosarcoma: For the least aggressive grade, about 90% of patients survive more than five years after diagnosis. For the most aggressive grade, more than a quarter of patients live more than five years.
More about prognosis of Chondrosarcoma
Visit our research pages for current research about Chondrosarcoma treatments.
The US based website ClinicalTrials.gov lists information on both federally and privately supported clinical trials using human volunteers.
Some of the clinical trials listed on ClinicalTrials.gov for Chondrosarcoma include:
See full list of 34 Clinical Trials for Chondrosarcoma
Related forums and medical stories:
Read about other experiences, ask a question about Chondrosarcoma, or answer someone else's question, on our message boards:
A malignant mesenchymal tumor arising from cartilage-forming tissues involving the bones (bone chondrosarcoma) or the soft tissues (extraskeletal chondrosarcoma). Bone chondrosarcoma usually affects middle-aged to elderly adults, and the pelvic bones, ribs, shoulder girdle, and long bones are the most common locations. Extraskeletal chondrosarcoma usually affects the deep soft tissues of the extremities and the region of head and neck. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion. -- 2003 - (Source - Diseases Database)
A malignant neoplasm of cartilage cells - (Source - WordNet 2.1)
Ophanet, a consortium of European partners,
currently defines a condition rare when it affects 1 person per 2,000.
They list Chondrosarcoma as a "rare disease".
Source - Orphanet
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2011 Health Grades Inc. All rights reserved. Last Update: 1 February, 2012 (4:25)
